Plandaí Biotechnology Inc. has provided updated information on the status of the company's operations.
September 4/Johannesburg, South Africa/Marketwired -- Plandaí Biotechnology Inc. has provided updated information on the status of the company's operations, specifically addressing the manufacturing facility in South Africa, status of clinical trials, and expectation for commencing sales.
Roger Duffield, chairman and chief executive officer of Plandaí Biotechnology, stated, "As a company, we're excited to announce that our subsidiary, Green Gold Biotechnologies, has completed its state-of-the-art production facility in Mpumalanga, South Africa, in the heart of our tea estate. The unique processing and extraction system we employ to ensure that our products are highly bioavailable requires that we use only live plant material. We are therefore constrained to have our factory onsite, enabling processing to commence within an hour of harvest. The 10,000 square meter building is now complete, the equipment has arrived, and installation will commence in the coming weeks.